| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $55.7M | +27.2% |
| SG&A Expense | $14.7M | +20.6% |
| Operating Income | -$70.4M | -25.8% |
| Income Tax | $0 | — |
| Net Income | -$68.5M | -32.2% |
| EPS (Basic) | -$1.33 | -31.7% |
| EPS (Diluted) | -$1.33 | -31.7% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.4M | +339.0% |
| Short-term Investments | $56.5M | -34.2% |
| Current Assets | $128.7M | +22.6% |
| Total Assets | $132.7M | +7.3% |
| Current Liabilities | $9.6M | +84.7% |
| Total Liabilities | $11.7M | +55.4% |
| Stockholders' Equity | $121.0M | +4.2% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$57.4M | -29.0% |
| Capital Expenditures | $153K | +0.0% |
| Investing Cash Flow | $48.7M | +148.0% |
| Financing Cash Flow | $63.0M | +444.7% |
| Free Cash Flow | -$57.5M | -28.9% |